EM:Prep 2020 | Article 10 - Idarucizumab for the Reversal of Dabigatran

(12:31)

Idarucizumab reversal of dabigatran in acute ischemic stroke and intracranial hemorrhage

(5:31)

Idarucizumab for Reversal of Direct Thrombin Inhibitor Dabigatran

(5:27)

Idarucizumab Reversal of Bleeding in Dabigatran-Anticoagulated Animals

(4:4)

Idarucizumab review video abstract 89130

(3:12)

Praxbind (idarucizumab)- reversal of the anticoagulant effects of dabigatran

(2:11)

Idarucizumab for Dabigatran Reversal

(10:33)

MyEMCert Key Advance | Anticoagulant Reversal Strategies

(6:6)

Anticoagulation Reversal Strategies

(11:35)

How do Direct Thrombin Inhibitors Work? (Dabigatran)

(14:42)

Hematology USMLE Step 1 — Anticoagulant Drugs — Boards and Beyond

(28:57)

Pharmacology - ANTICOAGULANTS \u0026 ANTIPLATELET DRUGS (MADE EASY)

(16:11)

Webinar | What's New in Anticoagulation Therapy?

(58:24)

Reversal of newer anticoagulants – When and how

(23:51)

CE: Anticoagulation Reversal Agents

(58:53)

Virta Webinar: Type 2 Diabetes IS Reversible

(39:2)

Importance of #NOACreversal #Idarucizumab

(34:34)

NEJM Group Open Forum: Idarucizumab for Dabigatran Reversal

(18:55)

SOP for idarucizumab application in stroke patients taking dabigatran

(5:40)

EM-LLSA 2020 - Reversal of Dabigatran

(8:53)

Inability of Idarucizumab 5gm to Completely Reverse Excessively High Dabigatran Concentrations

(2:47)

Reversal agents for the management of oral anticoagulant-associated ICH

(3:40)

Reversal of DOACs: Making critical advancements

(24:17)

Know your drugs: How Praxbind/Idarucizumab reverses Pradaxa's action, as Humanized monoclo antibody?

(7:14)

Anticoagulant Reversal

(4:22)

Reversal agents prior to IVT in patients taking DOACs

(5:11)

Praxbind

(3:1econd)

Reversal agents for direct oral anticoagulants for patients experiencing intracerebral haemorrhage

(34:25)